格隆匯APP獲悉,根據聯交所最新權益披露資料顯示,2022年6月2日,昭衍新藥(06127.HK)獲Aggregate of abrdn plc affiliated investment management entities在場內以每股均價61.0579港元增持11.58萬股,涉資約707.05萬港元。
增持後,Aggregate of abrdn plc affiliated investment management entities最新持股數目為548.93萬股,持股比例由8.85%上升至9.04%。